 

Date of Shareholders’ Particulars
resolution/ Effective
date

 

November 22, 2021 | Clause V of the MoA was amended to reflect the reclassification in authorized share capital from %541,766,000
divided into 111,764,930 Equity Shares of 22 each and 15,911,807 preference shares of 220 each to 254,766,000
divided into 270,883,000 equity shares of 22 each.

 

Major events and milestones of our Company

 

Calendar year Event

 

2007 Pharmaceutica Ventures Limited invested 2800 million, by subscribing to 45,720 equity shares, Peepul Capital
Fund II LLC invested 2 226.33 million by subscribing to 30,000 equity shares of the Company and NEA-IndoUS
Venture Capital LLC invested $5 million by subscribing to 11,620 equity shares of our Company (out of which
4,662 equity shares through conversion of Series A CPS.)

 

2012 EBITDA of our Company turned positive

 

2017 Gangadi Investments Private Limited acquired 122,347 equity shares, 12,000,000 unlisted redeemable preference
shares and 42,847,000 non-convertible debentures from MKCP Direct Investments (Mauritius) IV Limited,
MKCP Institutional Investor (Mauritius) III Limited, TVS Shriram Growth Fund IA and Indiaventure Trust —
Fund |

 

2019 PI Opportunities Fund - I invested acquiring 22.21% stake of our Company as on date, pursuant to purchase of
21,233 equity shares

 

2021 Lavender Rose invested 26.56 billion, acquiring a 24.58% stake of our Company as on date through primary and
secondary transactions.

 

2021 PI Opportunities Fund - I invested 222.10 million by subscribing to 160,147 Series C2 CCPS.

 

 

Awards, accreditations and recognitions received by our Company and Subsidiaries

 

 

 

 

 

 

Calendar Year Awards
2012 VC Circle Awards — Best VC-backed Healthcare Services Company
2017 Hans India - hmtv Business Excellence Award — Best in Retail category

 

Time and cost over-runs
Our Company and Subsidiaries have not experienced any time or cost overruns in relation thereto.
Defaults or re-scheduling of borrowings

There have been no defaults or re-scheduling/ re-structuring in relation to borrowings availed by our Subsidiaries from any
bank. As on the date of this Prospectus, our Company does not have any outstanding financial indebtedness.

Lock-out and strikes
There have been no lock-outs or strikes at any time in our Company or Subsidiaries.
Accumulated Profits or Losses

There are no accumulated profits and losses of any Subsidiaries that are not accounted for by our Company in the Restated
Consolidated Financial Information.

Significant financial and strategic partners
Our Company does not have any significant financial or strategic partners.

Launch of key products or services, entry into new geographies or exit from existing markets, capacity/ facility creation
or location of plants

For details of key products or services launched by our Company, entry into new geographies or exit from existing markets,
capacity/ facility creation or location of plants see “Our Business” on page 147.

172
